antivir
cell
thought
regul
whether
hepat
c
viru
hcv
hiv
infect
result
viral
control
asymptomat
persist
sever
diseas
though
reason
differ
outcom
remain
unclear
recent
genet
evid
howev
indic
correl
certain
natur
killer
nk
cell
receptor
progress
hiv
hcv
infect
impli
nk
cell
play
role
cellassoci
diseas
direct
nk
cellmedi
lysi
virusinfect
cell
may
contribut
antivir
defens
viru
infect
especi
murin
cytomegaloviru
mcmv
infect
mice
perhap
hiv
human
nk
cell
also
suspect
immunoregulatori
function
instanc
nk
cell
may
indirectli
regul
cell
respons
lyse
mcmvinfect
antigenpres
cell
contrast
mcmv
lymphocyt
choromening
viru
lcmv
infect
mice
seem
resist
direct
antivir
effect
nk
cell
role
nk
cell
regul
celldepend
viral
persist
immunopatholog
examin
mice
infect
lcmv
establish
model
hiv
hcv
infect
human
describ
threeway
interact
wherebi
activ
nk
cell
cytolyt
elimin
activ
cell
affect
tcell
function
exhaust
high
viru
dose
nk
cell
prevent
fatal
patholog
enabl
tcell
exhaust
viral
persist
medium
dose
nk
cell
paradox
facilit
lethal
cellmedi
patholog
thu
nk
cell
act
rheostat
regul
cellmedi
support
antivir
cell
control
viral
pathogenesi
persist
intraven
iv
inocul
mice
low
pfu
medium
pfu
high
pfu
dose
lcmv
strain
clone
result
differ
degre
patholog
indic
weight
loss
fig
histolog
analysi
lung
section
user
may
view
print
copi
download
text
datamin
content
document
purpos
academ
research
subject
alway
full
condit
use
lcmv
lymphocyt
choriomening
viru
pv
pichind
viru
mcmv
murin
cytomegaloviru
vv
vaccinia
viru
mhv
mous
hepat
viru
hcv
hepat
c
viru
waggon
et
al
day
pi
fig
high
dose
caus
precipit
drop
bodi
weight
first
week
infect
fig
right
thereaft
clonal
exhaust
delet
lcmvspecif
cell
result
persist
infect
associ
minim
lung
patholog
fig
right
surviv
fig
top
select
deplet
nk
cell
use
mab
supplement
fig
one
day
prior
high
dose
infect
result
mortal
day
infect
fig
top
associ
sever
pulmonari
edema
data
shown
reduc
viral
titer
day
pi
fig
right
high
dose
condit
therefor
presenc
nk
cell
promot
persist
prevent
mortal
contrast
benefici
role
nk
cell
high
dose
infect
nk
celldeplet
prevent
sever
weight
loss
fig
middl
tissu
patholog
fig
middl
associ
medium
dose
lcmv
twentythre
percent
controltr
mice
succumb
medium
dose
second
week
infect
lung
surviv
mice
exhibit
bronchu
associ
lymphoid
tissu
pulmonari
edema
interstiti
mononuclear
infiltr
lung
patholog
absent
nk
celldeplet
mice
uniformli
surviv
medium
dose
challeng
fig
bottom
moreov
high
level
replic
viru
persist
surviv
control
mice
day
pi
nk
celldeplet
result
complet
viral
clearanc
fig
middl
case
presenc
nk
cell
detriment
host
promot
immun
patholog
death
irrespect
presenc
nk
cell
inocul
low
dose
viru
uniformli
nonleth
control
nk
celldeplet
mice
day
pi
minim
weight
loss
fig
left
minim
lung
patholog
fig
left
viru
complet
clear
group
mice
day
low
dose
infect
data
shown
nk
cell
deplet
result
rapid
elimin
lcmv
liver
day
pi
fig
left
weight
loss
lung
patholog
mortal
observ
medium
doseinfect
wildtyp
mice
fig
b
occur
infect
celldefici
mice
nk
cell
deplet
mice
alter
weight
loss
viral
burden
supplement
fig
thu
nk
cell
regul
viral
clearanc
immunopatholog
lcmv
infect
celldepend
mechan
earli
day
medium
dose
infect
proport
number
lcmvspecif
cell
increas
mice
deplet
nk
cell
fig
supplement
fig
antivir
cell
mice
display
enhanc
abil
coproduc
tnf
supplement
fig
number
np
tetramerbind
cell
spleen
day
pi
increas
nk
celldeplet
mice
rel
nondeplet
control
mice
infect
dose
viru
fig
number
virusspecif
cell
also
amplifi
nk
cell
deplet
compar
control
mice
differ
day
medium
dose
infect
fig
moreov
coproduct
tnf
antivir
cell
augment
nk
cell
deplet
fig
supplement
fig
increas
magnitud
lcmvspecif
cell
respons
absenc
nk
cell
medium
dose
infect
correl
rapid
viral
clearanc
fig
deplet
nk
cell
use
care
titrat
dose
antiasialo
antibodi
elimin
nk
cell
cell
also
enhanc
antivir
cell
respons
medium
dose
infect
supplement
fig
enhanc
antivir
cell
respons
suggest
nk
cell
deplet
may
augment
prolifer
lcmvspecif
cell
transfer
cfselabel
cell
reveal
larger
popul
cfse
low
donor
fig
data
shown
cell
multipl
host
tissu
day
pi
high
dose
infect
absenc
nk
cell
also
greater
specif
lysi
viral
peptideco
target
cell
detect
convent
vivo
cytotox
assay
day
infect
supplement
fig
moreov
lcmvspecif
tcr
transgen
cell
transfer
recov
tissu
nk
celldeplet
recipi
mice
greater
number
controltr
mice
day
low
dose
infect
supplement
fig
togeth
result
indic
cell
repress
size
antivir
cell
respons
lcmv
infect
activ
cell
import
maintain
cell
function
lcmv
infect
assess
whether
cell
involv
nk
cell
suppress
lcmvspecif
cell
mice
treat
antibodi
concurr
deplet
nk
cell
wherea
deplet
nk
cell
prior
medium
dose
lcmv
infect
result
reduct
splenic
viral
titer
day
pi
rel
control
mice
fig
deplet
nk
cell
effect
viral
titer
increas
number
enhanc
multipl
cytokin
product
antivir
cell
caus
nk
cell
deplet
also
prevent
codeplet
cell
fig
contrast
codeplet
nk
cell
prevent
increas
gp
specif
cell
control
vs
vs
p
vs
control
day
medium
dose
infect
paradox
high
viru
dose
codeplet
nk
cell
prevent
sever
pulmonari
edema
fig
heighten
mortal
fig
associ
deplet
nk
cell
alon
experi
mice
harvest
day
pi
surviv
nk
celldeplet
mice
moribund
requir
euthanasia
doubledeplet
mice
display
rel
normal
vigor
liver
doubledeplet
mice
contain
pfu
liver
mice
deplet
nk
cell
alon
nk
pfu
vs
pfu
p
enhanc
lcmvspecif
cell
absenc
nk
cell
also
abrog
concurr
deplet
cell
supplement
fig
togeth
data
indic
cell
need
nk
cell
modul
antivir
cell
respons
associ
viral
clearanc
persist
immunopatholog
util
modifi
vivo
cytotox
assay
inject
splenocyt
medium
doseinfect
nk
celldeplet
mice
day
pi
medium
doseinfect
nk
celldeplet
isotyp
control
recipi
mice
day
pi
hour
similar
proport
total
donor
control
vs
b
cell
control
vs
recov
infect
recipi
regardless
nk
cell
deplet
likewis
recoveri
activ
hi
donor
cell
similar
spleen
control
mice
minim
loss
rel
uninfect
control
mice
fig
contrast
substanti
loss
activ
donor
cell
infect
rel
uninfect
recipi
loss
prevent
deplet
nk
cell
fig
magnitud
nk
celldepend
loss
activ
donor
cell
similar
low
medium
high
doseinfect
recipi
fig
activ
cell
donorand
hostderiv
infect
control
mice
stain
posit
apoptosi
indic
annexinv
comparison
naiv
donor
cell
activ
donor
cell
medium
doseinfect
recipi
mice
fig
contrast
activ
donor
cell
recoveri
low
phenotyp
donor
cell
alter
nk
celldeplet
data
shown
data
indic
nk
cell
wt
mice
select
rapidli
target
activ
cell
elimin
lcmv
infect
next
examin
involv
nk
cell
cytolyt
mediat
fasl
tnf
perforin
process
loss
activ
wt
donor
cell
infect
wt
recipi
mice
fig
seen
activ
lpr
fa
mutant
mous
donor
cell
transfer
wt
recipi
mice
wt
donor
cell
transfer
recipi
mice
fig
contrast
rel
littl
loss
activ
wt
donor
cell
host
fig
whose
retent
activ
donor
cell
significantli
differ
p
nk
celldeplet
wt
host
thu
nk
cell
elimin
activ
cell
mediat
perforindepend
pathway
requir
fa
tnf
previou
work
implic
target
activ
cell
murin
nk
cell
vitro
observ
differ
activ
wt
donor
cell
surviv
wt
vs
recipi
fig
wt
mice
treat
block
mab
data
shown
note
observ
express
ligand
activ
nk
cell
receptor
includ
trail
earli
activ
cell
nk
cellmedi
elimin
activ
donor
cell
also
occur
antibodydefici
mice
data
shown
preclud
role
antibodydepend
mechan
activ
cell
howev
express
much
higher
level
adhes
molecul
cell
molecul
previous
shown
trigger
nk
cell
cytotox
via
somewhat
surpris
observ
activ
cell
far
suscept
activ
cell
direct
kill
nk
cell
even
though
express
high
level
adhes
molecul
previous
shown
presenc
neg
signal
receptor
nk
cell
prevent
nk
cellmedi
lysi
activ
cell
found
express
ligand
upregul
cell
medium
dose
lcmv
infect
express
level
much
higher
activ
activ
cell
mfi
activ
activ
p
supplement
fig
order
assess
whether
nk
cellmedi
lysi
activ
cell
gener
principl
viru
infect
examin
loss
lcmvactiv
cell
follow
transfer
mice
inocul
unrel
arenaviru
pichind
viru
pv
coronaviru
mous
hepat
viru
mhv
interferon
induc
nk
cell
activ
poli
c
pi
c
three
stimuli
induc
measur
loss
activ
donor
cell
depend
upon
presenc
nk
cell
fig
reciproc
experi
cell
activ
infect
pv
mhv
vaccinia
viru
vv
mcmv
lost
upon
transfer
mice
infect
medium
dose
lcmv
nk
cell
present
fig
analysi
window
time
nk
cell
regul
cell
occur
lcmv
medium
dose
model
show
reduc
frequenc
activ
donor
cell
rel
uninfect
recipi
vivo
cytotox
assay
transfer
nk
cellsuffici
mice
one
two
three
four
five
day
infect
supplement
fig
frequenc
activ
donor
cell
increas
nk
cell
deplet
recipi
mice
day
day
pi
result
suggest
nk
cell
target
activ
cell
mainli
second
third
day
infect
cytolyt
activ
nk
cell
peak
result
show
nk
cell
play
crucial
role
control
virusassoci
morbid
mortal
persist
absenc
direct
nk
cellmedi
control
viru
replic
alter
number
polyfunction
virusspecif
cell
effect
activ
cell
presum
due
direct
cytotox
demonstr
rapid
perforindepend
elimin
activ
cell
nk
cell
short
term
vivo
cytotox
assay
observ
enhanc
annexin
reactiv
cell
presenc
nk
cell
effect
activ
nk
cell
cell
viru
clearanc
appear
indirect
depend
presenc
cell
known
produc
factor
preserv
tcell
viabil
function
suggest
threeway
interact
wherebi
nk
cell
suppress
cell
respons
therebi
prevent
augment
cell
respons
turn
directli
regul
viral
clearanc
immunopatholog
system
fig
observ
direct
nk
cellmedi
lysi
cell
viru
infect
distinct
publish
account
nk
cell
regul
antivir
cell
mcmv
infect
nk
cellmedi
lysi
virusinfect
cell
contribut
control
viral
burden
persist
mcmvinfect
dendrit
cell
dc
turn
regul
activ
antivir
cell
moreov
found
nk
celldepend
chang
number
antigenpres
function
splenic
dc
lcmv
infect
supplement
fig
consist
find
nk
cell
directli
regul
cell
possibl
concern
vivo
cellular
deplet
antibodi
potenti
affect
frequenc
nkt
regulatori
cell
frequenc
lymphocyt
spleen
lcmvinfect
mice
alter
day
infect
low
concentr
use
studi
supplement
fig
moreov
deplet
nk
cell
celldefici
nk
celldefici
mice
medium
dose
infect
enhanc
lcmvspecif
cell
respons
reduc
viral
load
supplement
fig
similar
wt
mice
therefor
lymphocyt
lineag
appear
dispens
nk
cell
immunoregulatori
function
lcmv
infect
adjust
dose
lcmv
inocula
one
gener
divers
pattern
cellregul
pathogenesi
similar
varieti
pathogen
pattern
human
hcv
infect
take
includ
rapid
viral
clearanc
sever
celldepend
immunopatholog
longterm
persist
show
high
dose
lcmv
nk
cell
act
benefici
suppress
cell
respons
therebi
prevent
sever
patholog
mortal
enabl
develop
persist
infect
mice
eventu
recov
clear
viru
medium
dose
inoculum
nk
cell
suppress
cell
detriment
host
viru
clearanc
impair
due
limit
number
function
cell
howev
medium
dose
viru
suffici
complet
clonal
exhaust
cell
ultim
result
sever
celldepend
immunopatholog
lead
death
host
result
suggest
nk
cell
serv
rheostat
master
regul
antivir
cell
respons
consist
fact
mani
viru
infect
induc
cytokin
potent
activ
nk
cell
found
nk
cell
lysi
activ
cell
trigger
sever
virus
well
inocul
pi
c
induc
interferon
activ
nk
cell
although
previou
studi
found
nk
cell
deplet
alter
magnitud
antivir
cell
respons
infect
armstrong
strain
lcmv
one
day
infect
male
select
deplet
nk
cell
singl
ip
inject
mab
control
rat
bioxcel
previous
describ
supplementari
fig
case
mice
also
deplet
cell
ip
inject
day
infect
mice
infect
iv
low
dose
medium
dose
high
dose
pfu
clone
variant
lcmv
viru
titrat
plaqu
assay
vero
cell
experi
mice
inocul
ip
pfu
pv
pfu
mhv
strain
pfu
vv
strain
western
reserv
pfu
smith
strain
mcmv
pi
c
invivogen
number
lcmvspecif
cell
measur
b
np
tetram
stain
intracellular
cytokin
stain
hour
ex
vivo
stimul
viral
peptid
presenc
brefeldin
cell
cytolyt
activ
measur
vivo
describ
previous
unconvent
vivo
cytotox
assay
previous
establish
determin
nk
cell
kill
lymphocyt
popul
donor
mice
deplet
nk
cell
infect
iv
ip
differ
virus
day
pi
singl
cell
splenocyt
suspens
prepar
mice
label
cfse
transfer
variou
strain
nk
celldeplet
control
recipi
mice
either
uninfect
infect
viru
day
previous
spleen
recipi
mice
harvest
hour
transfer
assess
surviv
donor
cell
clone
variant
lcmv
propag
babi
hamster
kidney
cell
titrat
plaqu
assay
vero
cell
mice
infect
iv
low
dose
medium
dose
high
dose
pfu
lcmv
select
deplet
nk
cell
achiev
singl
ip
inject
mab
control
rat
produc
bioxcel
previous
describ
supplementari
fig
altern
mice
receiv
care
titrat
dose
antiasialo
antibodi
wako
biochem
dilut
pb
ip
one
day
prior
viru
infect
mab
gift
l
lanier
inject
ip
time
infect
mice
deplet
cell
ip
inject
either
produc
bioxcel
day
day
infect
experi
mice
inocul
ip
pfu
pv
pfu
mhv
strain
pfu
vv
strain
western
reserv
pfu
smith
strain
mcmv
polyi
c
invivogen
tcell
epitop
encod
lcmv
includ
np
fqpqngqfi
gp
kavynfatc
gp
glkgpdiykgvyqfksvefd
peptid
purchas
st
centuri
biochem
purifi
revers
phasehplc
puriti
b
np
tetram
prepar
describ
tetram
provid
niaid
tetram
facil
gener
gift
l
berg
fluoresc
label
antibodi
reagent
purchas
bd
bioscienc
ebiosci
biolegend
r
biosystem
flow
cytometr
analys
cell
perform
lsr
ii
cytomet
bd
bioscienc
equip
facsdiva
softwar
data
analyz
use
flowjo
softwar
tree
star
spleen
donor
mice
mechan
disrupt
erythrocyt
lyse
use
nh
cl
solut
order
gener
singlecel
leukocyt
suspens
cell
label
min
fluoresc
dye
carboxyfluorescein
diacet
succinimidyl
ester
cfse
cfdase
molecular
probe
wash
transfer
iv
cell
recipi
mice
cell
cytolyt
activ
measur
vivo
describ
previous
briefli
singlecel
suspens
prepar
spleen
uninfect
mice
separ
fraction
cell
load
lcmv
peptid
minut
label
cfse
molecular
probe
minut
wash
popul
combin
equal
ratio
transfer
iv
either
infect
recipi
surviv
transfer
popul
spleen
recipi
mice
assess
hour
transfer
specif
lysi
calcul
follow
lcmv
target
popul
infect
experiment
unlabel
popul
infect
experiment
lcmv
target
popul
control
unlabel
popul
control
unconvent
vivo
cytotox
assay
previous
establish
determin
nk
cell
kill
lymphocyt
popul
vivo
wt
lpr
donor
mice
deplet
nk
cell
infect
vv
mcmv
mhv
pv
medium
dose
lcmv
clone
day
pi
singl
cell
splenocyt
suspens
prepar
mice
label
cfse
transfer
experiment
recipi
mice
day
medium
dose
lcmv
infect
unless
otherwis
note
recipi
includ
wt
tnf
mice
administ
isotyp
control
antibodi
one
day
prior
inocul
pv
mhc
polyi
c
variou
dose
lcmv
clone
recipi
mice
uninfect
serv
control
spleen
recipi
mice
harvest
hour
transfer
assess
surviv
donor
cell
stimul
cell
prepar
isol
singlecel
suspens
spleen
uninfect
well
isotypetr
mice
infect
day
previous
medium
dose
lcmv
iv
follow
irradi
stimul
cell
plate
ratio
cfselabel
lcmvspecif
cell
cell
stimul
medium
rpmi
supplement
uml
penicillin
g
streptomycin
sulfat
mm
lglutamin
mm
hepe
mm
sodium
pyruv
mm
nonessenti
amino
acid
mm
heatinactiv
min
fb
refresh
everi
two
day
cell
enumer
analyz
dilut
cfse
measur
prolifer
everi
hour
initi
cocultur
singlecel
leukocyt
suspens
spleen
inguin
lymph
node
lung
liver
prepar
describ
previous
plate
cell
per
well
well
plate
cell
stimul
hour
either
viral
peptid
mab
presenc
brefeldin
uml
stimul
cell
preincub
dilut
fc
block
fac
buffer
hbb
fc
nan
stain
min
variou
combin
fluoresc
tag
mab
wash
cell
permeabil
use
bd
cytofixcytoperm
solut
stain
bd
permwash
use
mab
specif
variou
cytokin
annexinv
stain
perform
azidefre
fac
buffer
directli
ex
vivo
accord
manufactur
instruct
bd
bioscienc
result
routin
display
mean
sem
statist
differ
experiment
group
determin
use
twotail
unpair
student
ttest
p
valu
deem
signific
statist
differ
surviv
determin
log
rank
mantelcox
analysi
graph
produc
statist
analys
perform
use
graphpad
prism
refer
web
version
pubm
central
supplementari
materi
